Brief: Wave Life Sciences Receives FDA Rare Pediatric Disease Designation For Wve-N531

Wave Life Sciences

12/08/2024 14:06

Aug 12 (Reuters) - WAVE Life Sciences Ltd  WVE.O :
    * WAVE LIFE SCIENCES RECEIVES FDA RARE PEDIATRIC DISEASE
DESIGNATION FOR WVE-N531 FOR THE TREATMENT OF DUCHENNE MUSCULAR
DYSTROPHY
    * DESIGNATION HIGHLIGHTS SIGNIFICANT UNMET NEEDS IN DMD
    * DYSTROPHIN DATA FROM POTENTIALLY REGISTRATIONAL FORWARD-53
TRIAL
OF WVE-N531 ARE ON TRACK FOR 3Q

Source text for Eikon:  ID:nGNX35rSLb 
Further company coverage:  WVE.O 

 ((Reuters.Briefs@thomsonreuters.com;))